Trial Profile
A Retrospective study to evaluate the impact of corticosteroids on Nivolumab treatment in patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary) ; Corticosteroids
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Jul 2018 New trial record
- 20 Jun 2018 Results published in the Journal of Thoracic Oncology